Founder of ARTSMedia Denmark, Stroebech IVF Universe, Stroebech Media and, EmbryoTrans Biotech
Dr Stroebech was the first in the world to formulate and market a commercial serum-free ready-to-use media range for animal IVF, sold to IVFBioscience, UK. In 4 years the media was positioned as global #1 best performing IVF media and protocol.
Established and was head of the bovine IVF research laboratory at Origio, Cooper Surgical Denmark.
Academic work:
Supervising international Phd students and Postdocs.
Research partner in research projects EliteOva, Elitesemen, Searmet, GIFT Brazil +20 publications within assisted reproductive technology and embryo physiology, co-attracted + 7 mio € in research funds within IVF related research projects.
Laboratory Director at IVF Laboratory at Faculty of Health and Medical Sciences
Department of Veterinary and Animal Sciences, Copenhagen Denmark.
Board positions:
Chairman of the board of Danish society of Reproduction and Fetal Development, DSRF
Board member at International Embryo Technology Society, IETS
Association of Embryo Transfer society Europe, AETE
IVF Experience:
Dr Stroebech has consulted with more than 300 IVF laboratories within animal research and animal production worldwide helping them get established or to improve results in existing laboratories.
 |
+45 25 32 08 25 |
 |
lotte.stroebech@artsmedia.dk |
Martin Thomsen has 15 years of experience as CFO and COO for international companies, doing business in China, USA, UK, Germany, Ukraine and Scandinavia. Furthermore, Martin Thomsen has been head of establishing 3 start-ups to successful companies. He has due diligence on the seller and buyer side as well as successful sale of a company to a private equity fund.
Martin Thomsen was in the lead of the establishment of a factory in Hundested, Denmark for Chinese investors, for production of infant formula for sale in China. Responsible for factory and production.
Martin Thomsen has extensive experience in contact and negotiations with banks, suppliers, auditors and public authorities.
|
+45 51921173 |
|
martin.thomsen@artsmedia.dk |
Martin Thomsen has 15 years of experience as CFO and COO for international companies, doing business in China, USA, UK, Germany, Ukraine and Scandinavia. Furthermore, Martin Thomsen has been head of establishing 3 start-ups to successful companies. He has due diligence on the seller and buyer side as well as successful sale of a company to a private equity fund.
Martin Thomsen was in the lead of the establishment of a factory in Hundested, Denmark for Chinese investors, for production of infant formula for sale in China. Responsible for factory and production.
Martin Thomsen has extensive experience in contact and negotiations with banks, suppliers, auditors and public authorities.
|
+45 51921173 |
|
martin.thomsen@artsmedia.dk |
Dr Avery is an international recognized pioneer within IVF and former associate professor (from the Veterinary Faculty, University of Copenhagen). Dr. Avery was for 27 years head of the IVF laboratory, and responsible for the research, which mainly included bovine, porcine and equine in vitro embryo technology. Dr Avery is a noteworthy embryologist, researcher and educator.
She became Doctor of Medicine, University Copenhagen, 1977 and PhD in Embryology, Royal Veterinary and Agricultural University, Copenhagen, 1991. And in 2007 Doctor in Veterinary Sciences, Royal Veterinary and Agricultural University, Copenhagen.
She has been a guest professor at Cornell University, New York, 1984, University Estate São Paulo, Jaboticabal, Brazil, 1993, University Wisconsin, Madison, 1996. Furthermore, she has been invited speaker to numerous national and international scientific conferences. She has worked from 2010 to currently, as Scientific Advisor and Consultant with Dr Stroebech optimizing and developing IVP media, and commercializing them into ready-to-use serum-free products. Thus, rendering a more accessible solution to IVP of bovine embryos and facilitated for more laboratories to implement the technique, without the trouble of media making and batch variation.
Ulrik Bangsbo Hansen is heading the Danish Life Science Sector Group at DLA Piper and has worked with the sector for almost 20 years.
The experience with the sector includes all kinds of corporate and commercial matters e.g. agreements concerning distribution, technology transfer, wholesalers, development, clinical trials, consultancy services, logistics, procurement etc.
Experience also includes regulatory and qualitative matters. Ulrik has been heading several complex restructuring projects and transactions.
Clients varies from some of the largest international companies to local MedTech and Biotech
Moreover, Ulrik has vast experience in corporate investments as well as the sale and purchase of enterprises and establishment of joint ventures. The assistance includes contract drafting, negotiating and due diligence where a large part of his advising concerns international issues.
Ulrik has served as chairman at Embryotrans ApS since 2016.
Ulrik regularly holds courses in company law, M&A and contract law.
Ulrik Bangsbo Hansen is heading the Danish Life Science Sector Group at DLA Piper and has worked with the sector for almost 20 years.
The experience with the sector includes all kinds of corporate and commercial matters e.g. agreements concerning distribution, technology transfer, wholesalers, development, clinical trials, consultancy services, logistics, procurement etc.
Experience also includes regulatory and qualitative matters. Ulrik has been heading several complex restructuring projects and transactions.
Clients varies from some of the largest international companies to local MedTech and Biotech
Moreover, Ulrik has vast experience in corporate investments as well as the sale and purchase of enterprises and establishment of joint ventures. The assistance includes contract drafting, negotiating and due diligence where a large part of his advising concerns international issues.
Ulrik has served as chairman at Embryotrans ApS since 2016.
Ulrik regularly holds courses in company law, M&A and contract law.
Professor Poul Hyttel holds a DVM, a PhD, and a Doctor of Veterinary Science degree from the former Royal Veterinary and Agricultural University (now incorporated into University of Copenhagen) where he has served as Professor of Anatomy for more than 40 years. Poul has conducted research in assisted reproductive technologies and stem cells, and he is internationally renowned for his electron microscopical visualizations of oocytes and embryos. Poul has now retired and shifted his focus into a more artistic avenue and serves ARTSMedia Denmark by providing graphically reworked micrographs and drawings.